NCT06656364--Esprit BTK Post-Approval Study
Research payments
$1,524,226
Through program year 2025, $1,524,226 in research payments was reported against NCT06656364--Esprit BTK Post-Approval Study, across 649 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,524,226 | 649 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Richard Pin North Dartmouth, MA Named on 42 payments
- Anvar Babaev New York, NY Named on 38 payments
- Brian De Rubertis New York, NY Named on 33 payments
- Manuel Garcia-Toca Stanford, CA Named on 30 payments
- Prakash Krishnan New York, NY Named on 27 payments
- Kristofer Charlton-Ouw Houston, TX Named on 26 payments
- Michael Siah Dallas, TX Named on 26 payments
- Katherine Kane Fort Worth, TX Named on 24 payments
- Mitchell Weinberg Manhasset, NY Named on 22 payments
- Yazan Khatib Jacksonville, FL Named on 21 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.